* If you want to update the article please login/register
Purpose: The aim of this study is to investigate the role of hyaluronic acid filler injection in the treatment of upper eyelid retraction in thyroid eye disease management. One patient had 0. 35cc on the right eye and 0. 65 cm on the left eye, and one patient had 0. 65cc on the left eye, with the left eye having 0. 35cc on the right eye and 0. 65cc on the left eye. At different time points post-filler, there was no correlation between pre-filler MRD1 and rise in MRD1 change, nor was there any association between pre-filler upper scleral display and change in U. S. post-filler. There were also no correlations found between clinical fitness measures and MRD1 change in MRD1, as well as the duration of thyroid eye disease and change in MRD1. Transconjunctival HA injection is a safe treatment option for TED-related UER in both active and inactive TED patients in an East Asian population, with a potentially long-lasting effect.
Source link: https://europepmc.org/article/MED/36082627
Hyaluronic acid injection has emerged as a new and effective way to prevent premature ejaculation. In our review, a retrospective analysis of 85 patients who received HA injection from January 2018 to December 2019 was looked at retrospectively. A injection at glans penis was administered to 31 patients, and 54 patients were injected around coronary sulcus. At one month after intervention, a newborn's average intravaginal latency time increased from 123. 28s to 483. 543. 4s, then dropped to 332. 7. 50s and 278. 67s at a 3-month follow-up and a 6-month follow-up, respectively.
Source link: https://europepmc.org/article/PPR/PPR541736
* Please keep in mind that all text is summarized by machine, we do not bear any responsibility, and you should always check original source before taking any actions